Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

被引：60
作者：
Boissinot, Marjorie [1 ]
Lippert, Eric [1 ]
Girodon, Francois [1 ]
Dobo, Irene [1 ]
Fouassier, Marc [1 ]
Masliah, Claude [1 ]
Praloran, Vincent [1 ]
Hermouet, Sylvie [1 ]
机构：
[1] CHU Nantes, Lab Hematol, Inst Biol, F-44093 Nantes, France
来源：
BLOOD | 2006年 / 108卷 / 09期
关键词：
D O I：
10.1182/blood-2006-05-021527
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3223 / 3224
页数：2
相关论文
共 9 条
  • [1] The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)
    Boissinot, Marjorie
    Garand, Richard
    Hamidou, Mohamed
    Hermouet, Sylvie
    [J]. BLOOD, 2006, 108 (05) : 1781 - 1782
  • [2] Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis
    Chait, Y
    Condat, B
    Cazals-Hatem, D
    Rufat, P
    Atmani, S
    Chaoui, D
    Guilmin, F
    Kiladjian, JJ
    Plessier, A
    Denninger, MH
    Casadevall, N
    Valla, D
    Brière, JB
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (04) : 553 - 560
  • [3] Dobo I, 2004, HAEMATOLOGICA, V89, P1207
  • [4] Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera
    Dobo, L
    Donnard, M
    Girodon, F
    Mossuz, P
    Boiret, N
    Boukhari, R
    Allègraud, A
    Bascans, E
    Campos, L
    Pineau, D
    Turlure, P
    Praloran, V
    Hermouet, S
    [J]. HEMATOLOGY JOURNAL, 2004, 5 (02) : 161 - 167
  • [5] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
    James, C
    Ugo, V
    Le Couédic, JP
    Staerk, J
    Delhommeau, F
    Lacout, C
    Garçon, L
    Raslova, H
    Berger, R
    Bennaceur-Griscelli, A
    Villeval, JL
    Constantinescu, SN
    Casadevall, N
    Vainchenker, W
    [J]. NATURE, 2005, 434 (7037) : 1144 - 1148
  • [6] Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
    Kralovics, R
    Teo, SS
    Buser, AS
    Brutsche, M
    Tiedt, R
    Tichelli, A
    Passamonti, F
    Pietra, D
    Cazzola, M
    Skoda, RC
    [J]. BLOOD, 2005, 106 (10) : 3374 - 3376
  • [7] The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
    Lippert, Eric
    Boissinot, Marjorie
    Kralovics, Robert
    Girodon, Francois
    Dobo, Irene
    Praloran, Vincent
    Boiret-Dupre, Nathalie
    Skoda, Radek C.
    Hermouet, Sylvie
    [J]. BLOOD, 2006, 108 (06) : 1865 - 1867
  • [8] Mossuz P, 2004, HAEMATOLOGICA, V89, P1194
  • [9] The World Health Organization (WHO) classification of the myeloid neoplasms
    Vardiman, JW
    Harris, NL
    Brunning, RD
    [J]. BLOOD, 2002, 100 (07) : 2292 - 2302
1